| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | -0.0083 | 0.8 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.9 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | -0.0087 | 0.9 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.0064 | 0.9 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.9 |
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.9 |
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | -0.0092 | 0.9 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.0068 | 0.9 |